InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by NARACHI MICHAEL, Director. Director active across 1 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 3 reports have been logged. The latest transaction was disclosed on 24 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
03,300 shares0
Common Stock
SEC:0001209191-22-039565:0·
02,145 shares0
Common Stock
SEC:0001209191-21-043538·
02,145 shares0
Common Stock
SEC:0001209191-21-043538:0·
3 of 3 declarations
About NARACHI MICHAEL
Michael Narachi is a Director of Ultragenyx Pharmaceutical Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. His experience and skills in corporate governance are essential for guiding Ultragenyx Pharmaceutical Inc. in its growth and innovation objectives.
